Breaking News Instant updates and real-time market news.

BK

BNY Mellon

$40.68

0.11 (0.27%)

, SAN

Banco Santander

$4.42

-0.01 (-0.23%)

08:46
10/11/16
10/11
08:46
10/11/16
08:46

BNY Mellon appointed as depositary bank by Banco Santander S.A.

BNY Mellon (BK) has been appointed by Banco Santander S.A. (SAN) as the successor depositary bank for its American depositary receipt program. Each ADR represents one ordinary share and trades on the New York Stock Exchange under the symbol, 'SAN.' Banco Santander's ordinary shares trade on the Madrid Stock Exchange under the symbol, 'SAN.' In 2015, BNY Mellon announced that it had been chosen by Banco Santander Brasil as depositary bank for its ADR program and by Banco Santander Chile as successor depositary for its ADR program.

BK

BNY Mellon

$40.68

0.11 (0.27%)

SAN

Banco Santander

$4.42

-0.01 (-0.23%)

  • 20

    Oct

BK BNY Mellon
$40.68

0.11 (0.27%)

01/07/16
01/07/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADTRAN (ADTN) upgraded to Buy from Neutral at MKM Partners... Agilent (A) upgraded to Outperform, named a top pick at Cowen... Allscripts (MDRX) upgraded to Outperform from Sector Perform at RBC Capital... AmeriGas (APU) upgraded to Buy from Neutral at Janney Capital... American Airlines (AAL) upgraded to Outperform from Neutral at Credit Suisse... BNY Mellon (BK) upgraded to Overweight from Neutral at JPMorgan... Booz Allen (BAH) upgraded to Outperform from Market Perform at Wells Fargo... C.H. Robinson (CHRW) upgraded to Neutral from Sell at UBS... CACI (CACI) upgraded to Outperform from Market Perform at Wells Fargo... Calavo Growers (CVGW) upgraded to Buy from Neutral at DA Davidson... Cerner (CERN) upgraded to Top Pick from Outperform at RBC Capital... Charles River (CRL) upgraded to Outperform from Market Perform at Wells Fargo... Comerica (CMA) upgraded to Outperform from Neutral at Baird... Cousins Properties (CUZ) upgraded to Outperform from Neutral at Baird... Deutsche Bank (DB) upgraded to Overweight from Equal Weight at Barclays... Discover (DFS) upgraded to Buy from Hold at Deutsche Bank... EXFO Inc. (EXFO) upgraded to Sector Performer from Underperformer at CIBC... EverBank (EVER) upgraded to Strong Buy from Outperform at Raymond James... First Cash Financial (FCFS) upgraded to Buy from Neutral at Sterne Agee CRT... Hooker Furniture (HOFT) upgraded to Buy from Hold at BB&T... Host Hotels (HST) upgraded to Outperform from Neutral at Baird... Kilroy Realty (KRC) upgraded to Outperform from Neutral at Baird... McCormick (MKC) upgraded to Buy from Hold at Deutsche Bank... Noble Energy (NBL) upgraded to Buy from Hold at Deutsche Bank... Nordson (NDSN) upgraded to Buy from Hold at Wunderlich... Ocean Shore Holding (OSHC) upgraded to Buy from Hold at Sandler O'Neill... Olin Corp. (OLN) upgraded to Buy from Neutral at Nomura... Pioneer Natural (PXD) upgraded to Buy from Hold at Deutsche Bank... Public Storage (PSA) upgraded to Outperform from Neutral at Baird... RLI Corp. (RLI) upgraded to Market Perform from Underperform at Keefe Bruyette... Regency Centers (REG) upgraded to Outperform from Neutral at Baird... SAIC (SAIC) upgraded to Outperform from Market Perform at Wells Fargo... SL Green Realty (SLG) upgraded to Outperform from Neutral at Baird... Sierra Bancorp (BSRR) upgraded to Outperform from Market Perform at Raymond James... Southwest (LUV) upgraded to Equal Weight from Underweight at Morgan Stanley... State Street (STT) upgraded to Neutral from Underweight at JPMorgan... Sunstone Hotel (SHO) upgraded to Outperform from Neutral at Baird... VWR (VWR) upgraded to Market Perform from Underperform at Cowen... Wells Fargo (WFC) upgraded to Buy from Neutral at Citi.
01/11/16
GSCO
01/11/16
UPGRADE
GSCO
Conviction Buy
BNY Mellon upgraded to Conviction Buy from Neutral at Goldman
Goldman analyst Alexander Blostein upgraded BNY to Conviction Buy from Neutral and maintained his $48 price target on shares. Blostein expects BKY Mellon to have better than expected earnings growth driven by leverage to higher rates, cost discipline, and less beta exposure.
01/11/16
01/11/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AU Optronics (AUO) upgraded to Neutral from Underweight at JPMorgan... Air Products (APD) upgraded to Overweight from Sector Weight at KeyBanc... Amedisys (AMED) upgraded to Market Perform from Underperform at Raymond James... Ameriprise (AMP) upgraded to Outperform from Neutral at Credit Suisse... Analog Devices (ADI) upgraded to Outperform from Market Perform at Wells Fargo... Apple (AAPL) upgraded to Buy from Neutral at Mizuho... BAE Systems (BAESY) upgraded to Overweight from Neutral at JPMorgan... BNP Paribas (BNPQY) upgraded to Buy from Hold at Deutsche Bank... BNY Mellon (BK) upgraded to Conviction Buy from Neutral at Goldman... Banco Santander (SAN) upgraded to Outperform from Underperform at Exane BNP Paribas... Beiersdorf (BDRFF) upgraded to Neutral from Sell at Goldman... CEVA (CEVA) upgraded to Buy from Neutral at Ladenburg... Celanese (CE) upgraded to Buy from Neutral at SunTrust... Children's Place (PLCE) upgraded to Overweight at Morgan Stanley... Citizens Financial (CFG) upgraded to Buy from Neutral at Goldman... Clayton Williams (CWEI) upgraded to Market Perform from Underperform at Cowen... Concho Resources (CXO) upgraded to Outperform from Market Perform at Cowen... Crane (CR) upgraded to Buy from Hold at Vertical Research... Credit Agricole (CRARY) upgraded to Buy from Hold at Deutsche Bank... Denbury Resources (DNR) upgraded to Market Perform from Underperform at Cowen... Devon Energy (DVN) upgraded to Overweight from Equal Weight at Barclays... Discover (DFS) upgraded to Buy from Hold at Evercore ISI... Energen (EGN) upgraded to Outperform from Market Perform at Cowen... FS Investment (FSIC) upgraded to Buy from Hold at Cantor... First Horizon (FHN) upgraded to Buy from Hold at Evercore ISI... General Dynamics (GD) upgraded to Outperform from Market Perform at Cowen... General Motors (GM) upgraded to Outperform from Neutral at Credit Suisse... Genesco (GCO) upgraded to Overweight at Morgan Stanley... Hanesbrands (HBI) upgraded to Buy from Neutral at Nomura... Imperva (IMPV) upgraded to Buy from Neutral at Guggenheim... International Paper (IP) upgraded to Outperform from Sector Perform at RBC Capital... KeyCorp (KEY) upgraded to Buy from Neutral at Goldman... LVMH (LVMUY) upgraded to Neutral from Underperform at Credit Suisse... Laredo Petroleum (LPI) upgraded to Outperform from Market Perform at Cowen... Marathon Oil (MRO) upgraded to Overweight from Equal Weight at Barclays... Medifast (MED) upgraded to Buy from Neutral at Sidoti... Melco Crown (MPEL) upgraded to Overweight from Equal Weight at Morgan Stanley... Mellanox (MLNX) upgraded to Outperform on leverage to data growth at Credit Suisse... NASDAQ (NDAQ) upgraded to Neutral from Sell at Goldman... Newfield Exploration (NFX) upgraded to Outperform from Market Perform at Wells Fargo... OMA Airports (OMAB) upgraded to Neutral from Sell at Goldman... ONEOK (OKE) upgraded to Buy from Hold at Argus... Owens Corning (OC) upgraded on favorable risk/reward at RBC Capital... Patterson-UTI (PTEN) upgraded to Outperform from Market Perform at Wells Fargo... Pinnacle Foods (PF) upgraded to Outperform from Market Perform at BMO Capital... Pioneer Natural (PXD) upgraded to Equal Weight from Underweight at Barclays... RPC, Inc. (RES) upgraded to Outperform from Market Perform at Wells Fargo... RSP Permian (RSPP) upgraded to Outperform from Market Perform at Cowen... Rayonier Advanced Materials (RYAM) upgraded to Sector Perform from Underperform at RBC Capital... Regal-Beloit (RBC) upgraded to Overweight from Equal Weight at Morgan Stanley... Sanderson Farms (SAFM) upgraded to Overweight from Neutral at JPMorgan... Santander Mexico (BSMX) upgraded to Neutral from Underperform at BofA/Merrill... Southwest (LUV) upgraded to Equal Weight from Underweight at Morgan Stanley... Spectra Energy Partners (SEP) upgraded to Overweight from Equal Weight at Barclays... Superior Energy (SPN) upgraded to Outperform from Market Perform at Wells Fargo... Syntel (SYNT) upgraded to Neutral from Underweight at JPMorgan... U.S. Silica (SLCA) upgraded to Outperform from Market Perform at Wells Fargo... United Bankshares (UBSI) upgraded to Neutral at Boenning & Scattergood... Virtu Financial (VIRT) upgraded to Buy from Neutral at Goldman... Weatherford (WFT) upgraded to Outperform from Market Perform at Wells Fargo... Wells Fargo (WFC) upgraded to Buy from Neutral at Goldman... Whiting Petroleum (WLL) upgraded to Outperform from Market Perform at Wells Fargo... Wyndham (WYN) upgraded to Hold from Sell at Deutsche Bank.
04/22/16
ARGS
04/22/16
DOWNGRADE
ARGS
Hold
BNY Mellon downgraded to Hold from Buy at Argus
Argus analyst Stephen Biggar downgraded BNY Mellon to Hold citing the strong run-up in shares.
SAN Banco Santander
$4.42

-0.01 (-0.23%)

08/31/16
DBAB
08/31/16
UPGRADE
DBAB
Buy
Banco Santander upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Banco Santander to Buy citing strong earnings momentum and an attractive valuation.
08/31/16
08/31/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PNC Financial (PNC) upgraded to Outperform from Market Perform at Keefe Bruyette after transferring coverage to analyst Brian Klock. The analyst views the current valuation as attractive and sees opportunity for multiple expansion given PNC's diversified revenue stream. He upped the price target for the shares to $96 from $93. 2. Banco Santander (SAN) upgraded to Buy from Hold at Deutsche Bank, citing strong earnings momentum and an attractive valuation. 3. Pure Storage (PSTG) upgraded to Outperform from Perform at Oppenheimer by analyst Ittai Kidron, who thinks "too much negativism" is priced into the shares at current levels. The analyst believes FlashBlade can more than double Pure's addressable market longer term. Kidron set a $15 price target for the shares. 4. Digital Turbine (APPS) upgraded to Buy from Neutral at Ladenburg Thalmann, as analyst Jon Hickman believes new partner roll-outs in 2017 should improve revenue growth. The analyst raised his price target for the shares to $2.35 from $1.15. 5. Celadon Group (CGI) upgraded to Outperform from Market Perform at Avondale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
LEHM
09/06/16
UPGRADE
LEHM
Overweight
Banco Santander upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Rohith Chandrarajan upgraded Banco Santander to Overweight with a price target of EUR 4.70.
09/06/16
09/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intel (INTC) upgraded to Buy from Hold at Evercore ISI with analyst C.J. Muse saying fears of a slowdown in its Server business and sustained weakness in PCs have led Intel shares to underperform peers thus far in 2016. 2. Finisar (FNSR) upgraded to Buy from Hold at Stifel with analyst Patrick Newton saying he thinks that the outlook for demand for the company's 100G portfolio has improved, while worries about the competition facing the company's QSFP28 product are overdone. 3. Five Below (FIVE) upgraded to Neutral from Sell at Goldman with analyst Stephen Tanal saying the company has a compelling growth profile but shares are priced to perfection. 4. Banco Santander (SAN) upgraded to Overweight from Equal Weight at Barclays. 5. Michaels (MIK) upgraded to Outperform from Neutral at Credit Suisse with analyst Seth Sigman saying shares offer favorable risk/reward following the recent pullback and reaffirmed its $29 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

XLRN

Acceleron

$36.29

1.25 (3.57%)

, CELG

Celgene

$117.63

-1.24 (-1.04%)

19:23
12/04/16
12/04
19:23
12/04/16
19:23
Hot Stocks
Acceleron, Celgene report updated data from Phase 2 luspatercept studies »

Acceleron Pharma (XLRN)…

XLRN

Acceleron

$36.29

1.25 (3.57%)

CELG

Celgene

$117.63

-1.24 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

19:05
12/04/16
12/04
19:05
12/04/16
19:05
Hot Stocks
Alnylam reports Phase 2 data on fitusiran in hemophilia »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$122.96

0.95 (0.78%)

19:01
12/04/16
12/04
19:01
12/04/16
19:01
Hot Stocks
Alexion reports data from Phase 1/2 ALXN1210 study »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

LYV

Live Nation

$27.07

-0.44 (-1.60%)

18:58
12/04/16
12/04
18:58
12/04/16
18:58
Hot Stocks
Live Nation acquires 51% stake in Australia's Secret Sounds Group »

Live Nation Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$68.17

0.42 (0.62%)

18:45
12/04/16
12/04
18:45
12/04/16
18:45
Hot Stocks
Novartis reports Phase 2 data on CTL019 in leukemia »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ABBV

AbbVie

$59.43

0.27 (0.46%)

, JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

18:29
12/04/16
12/04
18:29
12/04/16
18:29
Hot Stocks
AbbVie reports five-year IMBRUVICA data, updated RESONATE-2 data »

AbbVie (ABBV) announced…

ABBV

AbbVie

$59.43

0.27 (0.46%)

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

CELG

Celgene

$117.63

-1.24 (-1.04%)

18:17
12/04/16
12/04
18:17
12/04/16
18:17
Hot Stocks
Celgene, Dana-Farber, U of Arkansas form Myeloma Genome Project »

Celgene, Dana-Farber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

ARQL

ArQule

$1.37

-0.01 (-0.72%)

18:12
12/04/16
12/04
18:12
12/04/16
18:12
Hot Stocks
ArQule reports data presentation on ARQ 092 in sickle cell disease »

ArQule announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$98.50

-0.44 (-0.44%)

, TWX

Time Warner

$93.80

-0.34 (-0.36%)

18:08
12/04/16
12/04
18:08
12/04/16
18:08
Hot Stocks
Box Office Battle: 'Moana,' 'Fantastic Beasts' win post-Thanksgiving weekend »

Disney's (DIS)…

DIS

Disney

$98.50

-0.44 (-0.44%)

TWX

Time Warner

$93.80

-0.34 (-0.36%)

VIA

Viacom

$40.35

-1 (-2.42%)

VIAB

Viacom

$36.52

-0.74 (-1.99%)

SNE

Sony

$28.06

-0.16 (-0.57%)

FOX

21st Century Fox

$27.37

-0.71 (-2.53%)

FOXA

21st Century Fox

$27.40

-0.8 (-2.84%)

LGF

Lionsgate

$22.72

0.02 (0.09%)

CMCSA

Comcast

$68.78

-1.08 (-1.55%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

17:09
12/04/16
12/04
17:09
12/04/16
17:09
Conference/Events
Starbucks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CS

Credit Suisse

$13.39

-0.34 (-2.48%)

17:03
12/04/16
12/04
17:03
12/04/16
17:03
Conference/Events
Credit Suisse to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

, SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

17:02
12/04/16
12/04
17:02
12/04/16
17:02
Hot Stocks
Takeda Pharma, Seattle Genetics reports Phase 3 ADCETRIS data »

Takeda Pharmaceutical…

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CGEN

Compugen

$5.95

0.1 (1.71%)

16:59
12/04/16
12/04
16:59
12/04/16
16:59
Conference/Events
Compugen to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

QURE

uniQure

$5.68

-0.31 (-5.18%)

16:56
12/04/16
12/04
16:56
12/04/16
16:56
Hot Stocks
uniQure reports data on AMT-060 in hemophilia B »

uniQure announced new and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 08

    Dec

RGLS

Regulus

$2.50

0.1 (4.17%)

16:53
12/04/16
12/04
16:53
12/04/16
16:53
Conference/Events
Regulus to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

PBI

Pitney Bowes

$14.63

0.1 (0.69%)

16:52
12/04/16
12/04
16:52
12/04/16
16:52
Conference/Events
Pitney Bowes to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

16:43
12/04/16
12/04
16:43
12/04/16
16:43
Hot Stocks
Seattle Genetics reports Phase 1b vadastuximab talirine data, plans Ph. 2 trial »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NVS

Novartis

$68.17

0.42 (0.62%)

16:38
12/04/16
12/04
16:38
12/04/16
16:38
Hot Stocks
Novartis reports Phase 2 SEG101 data »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PFE

Pfizer

$31.63

0.17 (0.54%)

16:33
12/04/16
12/04
16:33
12/04/16
16:33
Hot Stocks
Pfizer reports Phase 2 glasdegib data »

Pfizer announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

EKSO

Ekso Bionics

$4.27

-0.11 (-2.51%)

16:30
12/04/16
12/04
16:30
12/04/16
16:30
Conference/Events
Ekso Bionics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ADSK

Autodesk

$70.57

1.35 (1.95%)

16:24
12/04/16
12/04
16:24
12/04/16
16:24
Conference/Events
Autodesk to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Jan

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

16:23
12/04/16
12/04
16:23
12/04/16
16:23
Hot Stocks
Seattle Genetics reports Phase 2 ADCETRIS lymphoma data, says discontinues trial »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FTI

FMC Technologies

$35.60

0.9 (2.59%)

, TKPPY

Technip

$17.80

0.45 (2.59%)

16:21
12/04/16
12/04
16:21
12/04/16
16:21
Conference/Events
Technip to host special shareholder meeting »

Special Shareholder…

FTI

FMC Technologies

$35.60

0.9 (2.59%)

TKPPY

Technip

$17.80

0.45 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TKPPY

Technip

$17.80

0.45 (2.59%)

, FTI

FMC Technologies

$35.60

0.9 (2.59%)

16:14
12/04/16
12/04
16:14
12/04/16
16:14
Conference/Events
FMC Technologies to host special shareholder meeting »

Special Shareholder…

TKPPY

Technip

$17.80

0.45 (2.59%)

FTI

FMC Technologies

$35.60

0.9 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

16:04
12/04/16
12/04
16:04
12/04/16
16:04
Hot Stocks
Alnylam reports interim Phase 1 data on fitusiran »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.